Article
COVID-19 first and delta waves in relation to ACEI, ARB, Influenza vaccination, and comorbidity in a North Metropolitan Barcelona Health Consortium
2021-11-17
Abstract excerpt
<h4>ABSTRACT</h4> <h4>BACKGROUND</h4> Some authors have reported that angiotensin converter enzyme inhibitors (ACEI) and angiotensin receptor blockers (ARB) improve clinical outcomes in hypertensive COVID-19 patients, and others have proposed cross-protection for influenza vaccination. This study explores the impact of these variables on the evolution of hospitalized patients, focusing in the first wave and the De...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 550f7f78-33d3-5f9b-aade-8b68b3083ec3
- DOI
- 10.1101/2021.11.17.21265440
